share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer RICHMOND TIMOTHY J.

SEC announcement ·  Mar 6 06:34
Summary by Futu AI
On March 1, 2024, Timothy J. Richmond, EVP and Chief HR Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. Richmond acquired 45,700 shares through the exercise of derivative securities at a price of $61.36 per share. Subsequently, he sold a total of 75,680 shares in multiple open market transactions at prices ranging from $176.35 to $177.71, resulting in a total market value of $13,415,503. After these transactions, Richmond's direct holdings in AbbVie common stock amounted to 13,837 shares.
On March 1, 2024, Timothy J. Richmond, EVP and Chief HR Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. Richmond acquired 45,700 shares through the exercise of derivative securities at a price of $61.36 per share. Subsequently, he sold a total of 75,680 shares in multiple open market transactions at prices ranging from $176.35 to $177.71, resulting in a total market value of $13,415,503. After these transactions, Richmond's direct holdings in AbbVie common stock amounted to 13,837 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.